Re: Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer

被引：10
|
作者：
Nielsen, Torsten O.
Cheang, Maggie C. U.
Chia, Stephen K.
Voduc, David
Gao, Dongxia
Leung, Samuel
Bernard, Philip S.
Perou, Charles M.
Ellis, Matthew J.
机构：
来源：
JOURNAL OF THE NATIONAL CANCER INSTITUTE | 2009年 / 101卷 / 24期
关键词：
ESTROGEN-RECEPTOR;
D O I：
10.1093/jnci/djp390
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1730 / 1730
页数：1
相关论文
共 50 条
  • [41] Conventional and digital Ki67 evaluation and their correlation with molecular prognosis and morphological parameters in luminal breast cancer
    Laura Pons
    Laura Hernández-León
    Ahmad Altaleb
    Esperança Ussene
    Roman Iglesias
    Ana Castillo
    Paula Rodríguez-Martínez
    Eva Castella
    Vanesa Quiroga
    Eudald Felip
    Beatriz Cirauqui
    Mireia Margelí
    Pedro Luis Fernández
    Scientific Reports, 12
  • [42] Effects of neoadjuvant trastuzumab, pertuzumab and palbociclib on Ki67 in HER2 and ER-positive breast cancer
    Gianni, Luca
    Colleoni, Marco
    Bisagni, Giancarlo
    Mansutti, Mauro
    Zamagni, Claudio
    Del Mastro, Lucia
    Zambelli, Stefania
    Bianchini, Giampaolo
    Frassoldati, Antonio
    Maffeis, Ilaria
    Valagussa, Pinuccia
    Viale, Giuseppe
    NPJ BREAST CANCER, 2022, 8 (01)
  • [43] Immunocytochemical results for HER2 and Ki67 in breast cancer touch-smear cell specimens are reliable
    Morimoto, Masami
    Bando, Yoshimi
    Nakagawa, Misako
    Takechi, Hirokazu
    Yoshida, Takahiro
    Honda, Junko
    Tadokoro, Yukiko
    Moriya, Takuya
    Sasa, Mitsunori
    Tangoku, Akira
    BREAST CANCER, 2016, 23 (04) : 577 - 582
  • [44] Evaluation of ER, PgR, HER2 and Ki67 as predictors of response to neoadjuvant chemotherapy for operable breast cancer
    Burcombe, RJ
    Makris, A
    Richman, PI
    Pittam, M
    Daley, F
    Nobe, S
    Wilson, GD
    BRITISH JOURNAL OF CANCER, 2001, 85 : 50 - 50
  • [45] Getting Deep in the Luminal B Breast Cancer Subtype and Its Ki67 Cutoff Value
    Ciruelos, E.
    Castaneda, C. A.
    Andres, E.
    Gomez, H. L.
    Manso, L.
    Ghanem, I.
    Cortes-Funes, H.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S363 - S364
  • [46] Discrepancy of labeling index Ki67 in ER positive HER2 negative breast cancer determined by image analysis software and visual assessment
    Kushnarev, V.
    Kudaibergenova, A.
    Artemyeva, A.
    VIRCHOWS ARCHIV, 2017, 471 : S203 - S203
  • [47] Interobserver concordance of Ki67 labeling index in breast cancer: Japan Breast Cancer Research Group Ki67 Ring Study
    Mikami, Yoshiki
    Ueno, Takayuki
    Yoshimura, Kenichi
    Tsuda, Hitoshi
    Kurosumi, Masafumi
    Masuda, Shinobu
    Horii, Rie
    Toi, Masakazu
    Sasano, Hironobu
    CANCER SCIENCE, 2013, 104 (11) : 1539 - 1543
  • [48] Ki67 labelling index (Ki67LI) can subdivide homogeneous HER2 negative luminal grading groups (HNL-GG) in distinct biological entities
    Ferro, A.
    Russo, L. M.
    Eccher, C.
    Triolo, R.
    Barbareschi, M.
    Caldara, A.
    Dipasquale, M.
    Galligioni, E.
    CANCER RESEARCH, 2013, 73
  • [49] Comparison of immunohistochemistry and RT-qPCR for assessing ER, PR, HER2, and Ki67 and evaluating subtypes in patients with breast cancer
    Lili Chen
    Yanyang Chen
    Zhongpeng Xie
    Jiao Luo
    Yuefeng Wang
    Jianwen Zhou
    Leilei Huang
    Hongxia Li
    Linhai Wang
    Pei Liu
    Man Shu
    Wenhui Zhang
    Zunfu Ke
    Breast Cancer Research and Treatment, 2022, 194 : 517 - 529
  • [50] Comparison of immunohistochemistry and RT-qPCR for assessing ER, PR, HER2, and Ki67 and evaluating subtypes in patients with breast cancer
    Chen, Lili
    Chen, Yanyang
    Xie, Zhongpeng
    Luo, Jiao
    Wang, Yuefeng
    Zhou, Jianwen
    Huang, Leilei
    Li, Hongxia
    Wang, Linhai
    Liu, Pei
    Shu, Man
    Zhang, Wenhui
    Ke, Zunfu
    BREAST CANCER RESEARCH AND TREATMENT, 2022, 194 (03) : 517 - 529
12345